TTK Healthcare Limited has informed the Exchange regarding Board meeting held on August 04, 2025.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 3.9 pts less than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TTK Healthcare reported Q1 FY26 revenue from operations of Rs. 226.43 crores, up about 9% from Rs. 207.90 crores in Q1 FY25. Total income stood at Rs. 244.36 crores. Profit after tax came in at Rs. 13.00 crores versus Rs. 31.58 crores in the year-ago quarter, but the comparison is heavily distorted by a one-time exceptional gain of Rs. 19.77 crores from the sale of leasehold land at Mahindra World City, Chennai booked in Q1 FY25. Profit before tax (before exceptional items) declined to Rs. 17.65 crores from Rs. 21.02 crores, suggesting some underlying margin pressure as other expenses rose sharply. Basic EPS was Rs. 9.20 compared to Rs. 22.35 in Q1 FY25. Consumer Products, Medical Devices and Protective Devices segments posted strong sequential revenue growth. Statutory auditors PKF Sridhar & Santhanam LLP issued an unqualified limited review report.
The sharply lower PAT is largely explained by the absence of last year's one-time land sale gain rather than a real business collapse; investors should focus on segment-wise growth and margin trends in the coming quarters for a cleaner read on operating performance.